LY-503430
id:
ly-503430-191-8988384
title:
LY-503430
text:
LY-503430 is an AMPA receptor positive allosteric modulator developed by Eli Lilly. LY-503430 produces both nootropic and neuroprotective effects, reducing brain damage caused by 6-hydroxydopamine or MPTP and also increasing levels of the neurotrophic factor BDNF in the brain, particularly in the substantia nigra, hippocampus, and striatum. It is orally active and the main application it is currently being developed for is treatment of Parkinson's disease, although it has also been proposed to b
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/LY-503430
date created:
date modified:
2023-12-27T00:38:03Z
main entity:
{"identifier":"Q6460436","url":"https://www.wikidata.org/entity/Q6460436"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/8/84/LY503430.svg","width":174,"height":309}
fields total:
13
integrity:
15